0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 41-42 of 42 Articles
Original Contribution |  FREE
William J. Catalona, MD; Alan W. Partin, MD, PhD; Kevin M. Slawin, MD; et al.
JAMA. 1998;279(19):1542-1547. doi:10.1001/jama.279.19.1542.

Medical News & Perspectives | 
Phil Gunby
JAMA. 1998;279(13):982-983. doi:10.1001/jama.279.13.982-JMN0401-3-1.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Review  | 
The Evolving Landscape of HER2 Targeting in Breast Cancer
Mark M. Moasser, MD; Ian E. Krop, MD, PhD
JAMA Ophthalmology
Original Investigation  | 
Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma
Ana V. Torbidoni, PhD; Viviana E. Laurent, MSc; Claudia Sampor, MD; et al.
JAMA Oncology
Viewpoint  | 
How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy
Michael D. Farwell, MD; Amy S. Clark, MD, MSCE; David A. Mankoff, MD, PhD
JAMA Oncology
Original Investigation  | 
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab A Secondary Analysis of the NeoALTTO Trial
Roberto Salgado, MD, PhD; Carsten Denkert, MD, PhD; Christine Campbell, MSc; et al.